Suchergebnisse - "van de Donk, Niels W C J"

PubPharm (26)

11

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

enthalten in: Blood | 2016

von Zweegman, S. | van der Holt, B. | Mellqvist, U. | +25

12

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

enthalten in: Blood | 2016

von van de Donk, N. | Moreau, P. | Plesner, T. | +9

13

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma

enthalten in: Blood | 2016

von Palumbo, A. | Avet-Loiseau, H. | Malavasi, F. | +9

14

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

enthalten in: Blood | 2016

von Zweegman, S. | van der Holt, B. | Mellqvist, U. | +25

15

Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

enthalten in: Blood | 2016

von Sonneveld, P. | Avet-Loiseau, H. | Lonial, S. | +18

16

Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

enthalten in: Blood | 2016

von Krejcik, J. | Casneuf, T. | Nijhof, I. | +11

17

CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma

enthalten in: Blood | 2016

von Nijhof, I. | Casneuf, T. | van Velzen, J. | +14

18

Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities : intravascular lymphoma

enthalten in: Blood | 2014

von van Rhenen, A. | van de Donk, N.

19

Rapidly progressive neurological deterioration without magnetic resonance imaging abnormalities: intravascular lymphoma

enthalten in: Blood | 2014

von van Rhenen, A. | van de Donk, N.

20

Leptomeningeal metastases from primary plasma cell leukemia

enthalten in: Blood | 2013

von van de Donk, N. | Lokhorst, H.